Scientists at the forefront of regenerative medicine, based at the esteemed Karolinska Institutet and KTH Royal Institute of Technology in…
Read More
Ludwig Cancer Research Study Reveals Novel Combination Therapy for Acute Myelogenous Leukemia Targeting Epigenetic Barriers to Cell Differentiation
A collaborative international study led by researchers at Ludwig Cancer Research has identified a breakthrough therapeutic strategy for acute myelogenous…
Read More
Discovery of Fam102a Protein as a Novel Bone Remodeling Factor Offers New Pathway for Osteoporosis Treatment
In a landmark study published in the journal Nature Communications on January 2, 2025, a research team led by Professor…
Read More
King’s College London Researchers Discover Novel Aluminum Structure Capable of Replacing Precious Metals in Industrial Catalysis
A team of scientists at King’s College London has identified a new form of aluminum, one of the most abundant…
Read More
Groundbreaking Research Uncovers How Cellular Tunnels Drive Huntington’s Disease Progression, Revealing Novel Therapeutic Avenue
A recent scientific breakthrough, spearheaded by a team of researchers from Florida Atlantic University (FAU), has fundamentally reshaped our understanding…
Read More
Comprehensive Infographic Illuminates Advances in Spatial Data Collection: Comparing Imaging, Capture, and Novel Donation-Based Sequencing Techniques
The landscape of biological research is undergoing a profound transformation, driven by an increasing demand to understand molecular processes within…
Read More
Calcium Signaling in Brain Immune Cells Identified as a Key Regulator of Anxiety, Opening Doors for Novel Treatments
A groundbreaking discovery by researchers at the University of Utah Health, led by Nobel laureate Mario Capecchi, has identified a…
Read More
Bayer Acquires Perfuse Therapeutics for Up to $2.45 Billion to Bolster Ophthalmology Pipeline with Novel Endothelin Receptor Antagonist
Bayer AG is set to significantly expand its presence in the ophthalmology market with the acquisition of Perfuse Therapeutics, a…
Read More
UCB Acquires Candid Therapeutics for Up to $2.2 Billion to Bolster Autoimmune Disease Pipeline with Novel T-Cell Engagers
UCB’s strategic move to acquire Candid Therapeutics for an initial $2 billion upfront, with an additional $200 million in milestone…
Read More
Unveiling a Novel Mechanism: Light-Induced p-Coumaric Acid Strengthens Plant Tissues, Potentially Regulating Growth
The intricate dance between light and plant development, a cornerstone of terrestrial life, continues to reveal its complexities as scientists…
Read MoreYOU MAY HAVE MISSED
